ClinicalTrials.gg
Drug

Treprostinil clinical trials

Also written Tyvaso, Remodulin, UT-15C and UT-15.

studies test it
99
open now
13
in phase 3
33
first study started
1998

How each study uses treprostinil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the treprostinil studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 May 2002 · REMODULIN · NDA 021272 (FDA, Drugs@FDA)
European Union
3 Apr 2020 · Trepulmix · EMEA/H/C/005207 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Inhaled Treprostinil
17
Treprostinil
17
Oral treprostinil
14
treprostinil diethanolamine
12
UT-15C SR
8

Brand

Tyvaso
17
Remodulin
17
Orenitram
7
YUTREPIA
1

Development codes

UT-15C
7
UT-15
2
L606
1

Studies by the year they started

99 studies that test it; most in 2017 (9)

Studies that test treprostinil, by start year
YearStudies
19981
20021
20032
20053
20064
20073
20087
20096
20108
20111
20128
20133
20142
20155
20166
20179
20186
20196
20202
20212
20223
20233
20254
20264

Who runs them

Industry 71 · Other 28

United Therapeutics (60) · Liquidia Technologies, Inc. (6) · Stanford University (3) · Eli Lilly and Company (2) · Brigham and Women's Hospital (2) · University of Florida (1) · Mayo Clinic (1) · Pharmosa Biopharm Inc. (1)

Often tested with

Tested in the same studies.

Sodium Citrate (1) · Citric Acid (1) · Magnesium Chloride (1) · Insulin Lispro (1) · Iloprost (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5, 1 in phase 3

Studies that test treprostinil, phase 3 first.

Studies

Open first, then newest update. How each study uses treprostinil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 99

See all 99 studies that test treprostinil →

Given beside what is tested · 2 — treprostinil is usual care or a partner of the new treatment

Codes

What other systems call treprostinil · ClinicalTrials.gg INT004347

  • MeSH (NLM) C427248treprostinilConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) RUM6K67ESGTREPROSTINILConfirmed FDA, NLM, Wikidata
  • RxNorm 343048Confirmed FDA, Wikidata
  • Wikidata Q3495231treprostinilConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C61983TreprostinilOne source FDA
  • DrugBank DB00374One source Wikidata

Also registered as treprostinil diolamine (UNII H1FKG90039 · RxNorm 1927409) and treprostinil sodium (UNII 7JZ75N2NT6 · RxNorm 342691).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.